EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Polymer- and lipid-based nanocarriers for ocular drug delivery: Current status and future perspectives

Haijie Han, Su Li, Mingyu Xu, Yueyang Zhong, Wenjie Fan, Jingwei Xu, Tinglian Zhou, Jian Ji, Juan Ye, Ke Yao

Advanced Drug Delivery Reviews · 2023-05 · 196 · 114770

DOI: 10.1016/j.addr.2023.114770 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2023-05. Verfasst von Haijie Han und 9 weiteren Autor:innen. Beteiligte Einrichtung: Eye Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University, 88 Jiefang Road, Hangzhou 310009, People's Republic of China; Zh…. Hauptthemen laut MEDLINE: Drug Carriers, Nanoparticles. Die Arbeit wurde bisher 320-mal zitiert (Crossref) und nennt 454 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, Shanxi Provincial Key Research and Development Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ocular diseases seriously affect patients' vision and life quality, with a global morbidity of over 43 million blindness. However, efficient drug delivery to treat ocular diseases, particularly intraocular disorders, remains a huge challenge due to multiple ocular barriers that significantly affect the ultimate therapeutic efficacy of drugs. Recent advances in nanocarrier technology offer a promising opportunity to overcome these barriers by providing enhanced penetration, increased retention, improved solubility, reduced toxicity, prolonged release, and targeted delivery of the loaded drug to the eyes. This review primarily provides an overview of the progress and contemporary applications of nanocarriers, mainly polymer- and lipid-based nanocarriers, in treating various eye diseases, highlighting their value in achieving efficient ocular drug delivery. Additionally, the review covers the ocular barriers and administration routes, as well as the prospective future developments and challenges in the field of nanocarriers for treating ocular diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug CarriersNanoparticlesHumansDrug Delivery SystemsEyeLipids

Stichwörter der Autor:innen

Lipid-based nanocarrierOcular barriersOcular diseasesOcular drug deliveryPolymer-based nanocarrier

Substanzen

Drug CarriersLipids

Autor:innen und Institutionen

  • Eye Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University, 88 Jiefang Road, Hangzhou 310009, People's Republic of China; Zhejiang Provincial Key Lab of Ophthalmology, The Second Affiliated Hosp…
  • Eye Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University, 88 Jiefang Road, Hangzhou 310009, People's Republic of China.
  • MOE Key Laboratory of Macromolecule Synthesis and Functionalization of Ministry of Education, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou 310027, People's Republic of China.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province
  • Shanxi Provincial Key Research and Development Project

Zitieren

APA

Han, H., Li, S., Xu, M., Zhong, Y., Fan, W., Xu, J., Zhou, T., Ji, J., Ye, J., & Yao, K. (2023). Polymer- and lipid-based nanocarriers for ocular drug delivery: Current status and future perspectives. Advanced Drug Delivery Reviews, 196, 114770. https://doi.org/10.1016/j.addr.2023.114770

Vancouver

Han H, Li S, Xu M, Zhong Y, Fan W, Xu J, et al. Polymer- and lipid-based nanocarriers for ocular drug delivery: Current status and future perspectives. Advanced Drug Delivery Reviews. 2023;196:114770. doi:10.1016/j.addr.2023.114770

BibTeX
@article{Han2023,
  author = {Han, Haijie and Li, Su and Xu, Mingyu and Zhong, Yueyang and Fan, Wenjie and Xu, Jingwei and Zhou, Tinglian and Ji, Jian and Ye, Juan and Yao, Ke},
  title = {Polymer- and lipid-based nanocarriers for ocular drug delivery: Current status and future perspectives},
  journal = {Advanced Drug Delivery Reviews},
  year = {2023},
  volume = {196},
  pages = {114770},
  doi = {10.1016/j.addr.2023.114770}
}
Kostenlos starten →